Pricing and market access
[click here]
Evidence-based insights for the pharmaceutical industry
With Inpharmation you gain access to decades of experience in delivering solutions that have been extensively validated for use in the pharmaceutical industry. All our approaches are designed to maximize your forecast accuracy, with deliverables that fit flexibly with your specific project requirements.
%
Reduction in pricing errors compared to traditional pricing methodologies.
Countries tracked in international reference pricing regulation database.
%
Reduction in peak demand forecasting error compared to simplistic approaches.
%
Reduction in relative forecast error provided by Inpharmation’s Pharma-Specific Conjoint versus choice-based conjoint.
Pharmaceutical executive training courses
Inpharmation’s Chairman, Gary Johnson, delivers Europe’s leading pharmaceutical forecasting and pricing executive training courses.
Find out more about our Pricing and Market Access Training and Forecasting Training.
"Europe's most respected pharma forecasting & pricing specialist consultancy."
Centre for Executive Leadership
OUR BOOKS:
Pharma-Specific Conjoint
Evidence-based conjoint analysis for an evidence-based industry
By Gary Johnson
Value Pricing for Market Access
Evidence-based pricing for pharmaceuticals
By Gary Johnson
Sales Forecasting for Pharmaceuticals
An evidence-based approach
By Gary Johnson
The AI Cube
Can we use AI in pharma pricing and forecasting?
By Gary Johnson and Sam Johnson